

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein neddylation (GO:0045116) | 8.24066802 |
| 2 | neutrophil activation involved in immune response (GO:0002283) | 7.71099959 |
| 3 | thrombin receptor signaling pathway (GO:0070493) | 7.53401465 |
| 4 | regulation of platelet aggregation (GO:0090330) | 6.24168297 |
| 5 | adenosine receptor signaling pathway (GO:0001973) | 5.85974424 |
| 6 | regulation of platelet activation (GO:0010543) | 5.77018981 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.63943264 |
| 8 | blood coagulation, intrinsic pathway (GO:0007597) | 5.51961870 |
| 9 | leukocyte migration involved in inflammatory response (GO:0002523) | 5.39358414 |
| 10 | platelet aggregation (GO:0070527) | 5.29966013 |
| 11 | negative regulation of thymocyte apoptotic process (GO:0070244) | 5.27399032 |
| 12 | lipoxygenase pathway (GO:0019372) | 5.00598123 |
| 13 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 4.97349356 |
| 14 | negative regulation of norepinephrine secretion (GO:0010700) | 4.94151483 |
| 15 | regulation of integrin-mediated signaling pathway (GO:2001044) | 4.84373901 |
| 16 | negative regulation of heart rate (GO:0010459) | 4.80041798 |
| 17 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.79738795 |
| 18 | negative regulation of platelet activation (GO:0010544) | 4.77153985 |
| 19 | positive regulation of endothelial cell differentiation (GO:0045603) | 4.70204456 |
| 20 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 4.66115113 |
| 21 | neutrophil activation (GO:0042119) | 4.57009663 |
| 22 | positive regulation of mast cell activation (GO:0033005) | 4.46851532 |
| 23 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.39461178 |
| 24 | low-density lipoprotein particle remodeling (GO:0034374) | 4.35924701 |
| 25 | negative regulation of response to food (GO:0032096) | 4.28275519 |
| 26 | negative regulation of appetite (GO:0032099) | 4.28275519 |
| 27 | positive regulation of cAMP-mediated signaling (GO:0043950) | 4.20463262 |
| 28 | megakaryocyte development (GO:0035855) | 4.13206294 |
| 29 | polyamine biosynthetic process (GO:0006596) | 4.12303677 |
| 30 | fusion of sperm to egg plasma membrane (GO:0007342) | 4.09993939 |
| 31 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 4.09364366 |
| 32 | angiogenesis involved in wound healing (GO:0060055) | 4.01310126 |
| 33 | granulocyte activation (GO:0036230) | 4.01164441 |
| 34 | positive regulation of systemic arterial blood pressure (GO:0003084) | 3.98517646 |
| 35 | negative regulation of protein localization to cell surface (GO:2000009) | 3.97884159 |
| 36 | positive regulation of macrophage differentiation (GO:0045651) | 3.97471993 |
| 37 | platelet degranulation (GO:0002576) | 3.97143262 |
| 38 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.95760277 |
| 39 | purinergic receptor signaling pathway (GO:0035587) | 3.94711247 |
| 40 | regulation of integrin activation (GO:0033623) | 3.87326545 |
| 41 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.79897954 |
| 42 | platelet formation (GO:0030220) | 3.76986506 |
| 43 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.70465060 |
| 44 | homotypic cell-cell adhesion (GO:0034109) | 3.69247793 |
| 45 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.67524116 |
| 46 | platelet activation (GO:0030168) | 3.67201288 |
| 47 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.66389106 |
| 48 | regulation of lipoprotein metabolic process (GO:0050746) | 3.59423785 |
| 49 | beta-amyloid metabolic process (GO:0050435) | 3.58715729 |
| 50 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.49238417 |
| 51 | regulation of norepinephrine secretion (GO:0014061) | 3.44949315 |
| 52 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.44025907 |
| 53 | negative regulation of T cell apoptotic process (GO:0070233) | 3.43303302 |
| 54 | positive regulation of receptor recycling (GO:0001921) | 3.38367085 |
| 55 | autophagic vacuole fusion (GO:0000046) | 3.36845363 |
| 56 | negative regulation of heart contraction (GO:0045822) | 3.33949576 |
| 57 | extracellular fibril organization (GO:0043206) | 3.32206610 |
| 58 | regulation of female receptivity (GO:0045924) | 3.31885057 |
| 59 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 3.31588107 |
| 60 | negative regulation of neural precursor cell proliferation (GO:2000178) | 3.29420931 |
| 61 | high-density lipoprotein particle remodeling (GO:0034375) | 3.28911906 |
| 62 | leukocyte degranulation (GO:0043299) | 3.24754226 |
| 63 | termination of signal transduction (GO:0023021) | 3.23126222 |
| 64 | mitochondrial calcium ion transport (GO:0006851) | 3.21708449 |
| 65 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.19892264 |
| 66 | regulation of mast cell degranulation (GO:0043304) | 3.18885506 |
| 67 | positive regulation of hemostasis (GO:1900048) | 3.18836802 |
| 68 | positive regulation of blood coagulation (GO:0030194) | 3.18836802 |
| 69 | regulation of mast cell activation (GO:0033003) | 3.14911105 |
| 70 | regulation of endothelial cell differentiation (GO:0045601) | 3.12430094 |
| 71 | cyclooxygenase pathway (GO:0019371) | 3.12402826 |
| 72 | positive regulation of mast cell degranulation (GO:0043306) | 3.10511062 |
| 73 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.10511062 |
| 74 | cellular biogenic amine biosynthetic process (GO:0042401) | 3.09975506 |
| 75 | regulation of cholesterol efflux (GO:0010874) | 3.09909028 |
| 76 | reverse cholesterol transport (GO:0043691) | 3.09622024 |
| 77 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.09422599 |
| 78 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.08590013 |
| 79 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.08269900 |
| 80 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.07826096 |
| 81 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.07826096 |
| 82 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 3.04390802 |
| 83 | negative regulation of catecholamine secretion (GO:0033604) | 2.99227459 |
| 84 | monoamine transport (GO:0015844) | 2.98701357 |
| 85 | regulation of megakaryocyte differentiation (GO:0045652) | 2.97292118 |
| 86 | vesicle targeting (GO:0006903) | 2.96759733 |
| 87 | phospholipid homeostasis (GO:0055091) | 2.95947390 |
| 88 | plasma membrane fusion (GO:0045026) | 2.95003172 |
| 89 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.93412551 |
| 90 | positive regulation of granulocyte differentiation (GO:0030854) | 2.93328855 |
| 91 | amine biosynthetic process (GO:0009309) | 2.92186071 |
| 92 | female mating behavior (GO:0060180) | 2.90959133 |
| 93 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.90363945 |
| 94 | phagocytosis, engulfment (GO:0006911) | 2.89798905 |
| 95 | endothelium development (GO:0003158) | 2.88025302 |
| 96 | regulation of memory T cell differentiation (GO:0043380) | 2.87491205 |
| 97 | cardiolipin metabolic process (GO:0032048) | 2.83862078 |
| 98 | positive regulation of protein homodimerization activity (GO:0090073) | 2.83076162 |
| 99 | positive regulation of coagulation (GO:0050820) | 2.82184572 |
| 100 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.82023326 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 5.02427329 |
| 2 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 4.65295325 |
| 3 | SCL_19346495_ChIP-Seq_HPC-7_Human | 4.30552604 |
| 4 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.52930784 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.47613016 |
| 6 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 3.30957805 |
| 7 | GATA1_19941826_ChIP-Seq_K562_Human | 3.12056253 |
| 8 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.05466901 |
| 9 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 3.00931887 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.84148405 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.62999383 |
| 12 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.61547633 |
| 13 | GATA2_19941826_ChIP-Seq_K562_Human | 2.60734414 |
| 14 | SPI1_23127762_ChIP-Seq_K562_Human | 2.36502741 |
| 15 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 2.35719563 |
| 16 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.34389436 |
| 17 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.33445866 |
| 18 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.32130613 |
| 19 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.31783731 |
| 20 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.28852712 |
| 21 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.28135039 |
| 22 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.21131536 |
| 23 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 2.19566668 |
| 24 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.11226913 |
| 25 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.08832215 |
| 26 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 2.01610874 |
| 27 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.97603861 |
| 28 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.96381549 |
| 29 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.90376418 |
| 30 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.85833195 |
| 31 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.77388626 |
| 32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.76766339 |
| 33 | GATA1_22025678_ChIP-Seq_K562_Human | 1.74698002 |
| 34 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.74157436 |
| 35 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.73604021 |
| 36 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.68224107 |
| 37 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.60059765 |
| 38 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.58679425 |
| 39 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.58316268 |
| 40 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.50451284 |
| 41 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.44110462 |
| 42 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.39418583 |
| 43 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.30271757 |
| 44 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29912245 |
| 45 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.27162282 |
| 46 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.22278126 |
| 47 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.21670136 |
| 48 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.21194736 |
| 49 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.19662759 |
| 50 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.15410123 |
| 51 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.15169175 |
| 52 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.14443379 |
| 53 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.14047392 |
| 54 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.13623254 |
| 55 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.12923283 |
| 56 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.12923283 |
| 57 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.12847329 |
| 58 | UTX_26944678_Chip-Seq_JUKART_Human | 1.12235083 |
| 59 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.08775481 |
| 60 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.06895080 |
| 61 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.05338129 |
| 62 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.05328807 |
| 63 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.02668540 |
| 64 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.01055613 |
| 65 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.00817105 |
| 66 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.00579546 |
| 67 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98750931 |
| 68 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.94642441 |
| 69 | MYB_26560356_Chip-Seq_TH2_Human | 0.93999691 |
| 70 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.93130110 |
| 71 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93076898 |
| 72 | GATA3_26560356_Chip-Seq_TH2_Human | 0.91895832 |
| 73 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.89736782 |
| 74 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.88777277 |
| 75 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87725027 |
| 76 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.86963821 |
| 77 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86472482 |
| 78 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.86095892 |
| 79 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84775278 |
| 80 | VDR_22108803_ChIP-Seq_LS180_Human | 0.84711379 |
| 81 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.84324314 |
| 82 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.83702379 |
| 83 | EWS_26573619_Chip-Seq_HEK293_Human | 0.80825414 |
| 84 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.80698727 |
| 85 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.80225768 |
| 86 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.80005202 |
| 87 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.78910328 |
| 88 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.78635069 |
| 89 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.78326045 |
| 90 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.77952096 |
| 91 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.76911215 |
| 92 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76566157 |
| 93 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.76296660 |
| 94 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.76246369 |
| 95 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.75512215 |
| 96 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.75271540 |
| 97 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.74662582 |
| 98 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.73766192 |
| 99 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.73318278 |
| 100 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.72902893 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005464_abnormal_platelet_physiology | 9.85947789 |
| 2 | MP0008004_abnormal_stomach_pH | 5.42427743 |
| 3 | MP0003724_increased_susceptibility_to | 3.79485937 |
| 4 | MP0000465_gastrointestinal_hemorrhage | 3.43428695 |
| 5 | MP0003303_peritoneal_inflammation | 2.85534855 |
| 6 | MP0005083_abnormal_biliary_tract | 2.46076842 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.45997301 |
| 8 | MP0002736_abnormal_nociception_after | 2.31695424 |
| 9 | MP0000343_altered_response_to | 2.20901191 |
| 10 | MP0005084_abnormal_gallbladder_morpholo | 2.19671989 |
| 11 | MP0000230_abnormal_systemic_arterial | 2.11158752 |
| 12 | MP0004510_myositis | 1.96611050 |
| 13 | MP0005410_abnormal_fertilization | 1.87655222 |
| 14 | MP0005671_abnormal_response_to | 1.77818274 |
| 15 | MP0008872_abnormal_physiological_respon | 1.77679397 |
| 16 | MP0010155_abnormal_intestine_physiology | 1.74232859 |
| 17 | MP0003566_abnormal_cell_adhesion | 1.73476530 |
| 18 | MP0005167_abnormal_blood-brain_barrier | 1.71292167 |
| 19 | MP0005397_hematopoietic_system_phenotyp | 1.71105121 |
| 20 | MP0001545_abnormal_hematopoietic_system | 1.71105121 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 1.69783377 |
| 22 | MP0003638_abnormal_response/metabolism_ | 1.69488577 |
| 23 | MP0001879_abnormal_lymphatic_vessel | 1.67159807 |
| 24 | MP0003828_pulmonary_edema | 1.66474011 |
| 25 | MP0001968_abnormal_touch/_nociception | 1.64092853 |
| 26 | MP0005058_abnormal_lysosome_morphology | 1.56620446 |
| 27 | MP0002132_abnormal_respiratory_system | 1.56031541 |
| 28 | MP0005000_abnormal_immune_tolerance | 1.54680247 |
| 29 | MP0002398_abnormal_bone_marrow | 1.54591126 |
| 30 | MP0004084_abnormal_cardiac_muscle | 1.54350119 |
| 31 | MP0005646_abnormal_pituitary_gland | 1.52433985 |
| 32 | MP0001851_eye_inflammation | 1.52000392 |
| 33 | MP0004130_abnormal_muscle_cell | 1.44921076 |
| 34 | MP0001663_abnormal_digestive_system | 1.44646463 |
| 35 | MP0003879_abnormal_hair_cell | 1.40884452 |
| 36 | MP0008775_abnormal_heart_ventricle | 1.38043685 |
| 37 | MP0003436_decreased_susceptibility_to | 1.37745025 |
| 38 | MP0000015_abnormal_ear_pigmentation | 1.27275261 |
| 39 | MP0002733_abnormal_thermal_nociception | 1.27061036 |
| 40 | MP0002723_abnormal_immune_serum | 1.26955860 |
| 41 | MP0004947_skin_inflammation | 1.25629978 |
| 42 | MP0000249_abnormal_blood_vessel | 1.22188866 |
| 43 | MP0001800_abnormal_humoral_immune | 1.21438186 |
| 44 | MP0005174_abnormal_tail_pigmentation | 1.20153057 |
| 45 | MP0002452_abnormal_antigen_presenting | 1.15711903 |
| 46 | MP0009764_decreased_sensitivity_to | 1.14126173 |
| 47 | MP0001533_abnormal_skeleton_physiology | 1.13903027 |
| 48 | MP0004036_abnormal_muscle_relaxation | 1.13447170 |
| 49 | MP0003136_yellow_coat_color | 1.13109535 |
| 50 | MP0000689_abnormal_spleen_morphology | 1.12808312 |
| 51 | MP0009763_increased_sensitivity_to | 1.11642647 |
| 52 | MP0002429_abnormal_blood_cell | 1.10736988 |
| 53 | MP0010329_abnormal_lipoprotein_level | 1.07660327 |
| 54 | MP0003866_abnormal_defecation | 1.07339335 |
| 55 | MP0002420_abnormal_adaptive_immunity | 1.03815628 |
| 56 | MP0001664_abnormal_digestion | 1.03727305 |
| 57 | MP0001819_abnormal_immune_cell | 1.02053321 |
| 58 | MP0002722_abnormal_immune_system | 1.01605711 |
| 59 | MP0008874_decreased_physiological_sensi | 1.01536468 |
| 60 | MP0000858_altered_metastatic_potential | 1.00996087 |
| 61 | MP0005409_darkened_coat_color | 0.98259955 |
| 62 | MP0009642_abnormal_blood_homeostasis | 0.97069294 |
| 63 | MP0000716_abnormal_immune_system | 0.96344852 |
| 64 | MP0009765_abnormal_xenobiotic_induced | 0.95452867 |
| 65 | MP0002419_abnormal_innate_immunity | 0.95381487 |
| 66 | MP0009278_abnormal_bone_marrow | 0.94332586 |
| 67 | MP0004215_abnormal_myocardial_fiber | 0.92413320 |
| 68 | MP0001845_abnormal_inflammatory_respons | 0.91107908 |
| 69 | MP0009697_abnormal_copulation | 0.89969727 |
| 70 | MP0001970_abnormal_pain_threshold | 0.89158722 |
| 71 | MP0005381_digestive/alimentary_phenotyp | 0.88655442 |
| 72 | MP0005025_abnormal_response_to | 0.87579620 |
| 73 | MP0000685_abnormal_immune_system | 0.86673104 |
| 74 | MP0009333_abnormal_splenocyte_physiolog | 0.86381273 |
| 75 | MP0003300_gastrointestinal_ulcer | 0.84660429 |
| 76 | MP0001765_abnormal_ion_homeostasis | 0.82857010 |
| 77 | MP0005666_abnormal_adipose_tissue | 0.80861406 |
| 78 | MP0006036_abnormal_mitochondrial_physio | 0.80668200 |
| 79 | MP0006276_abnormal_autonomic_nervous | 0.80329565 |
| 80 | MP0003656_abnormal_erythrocyte_physiolo | 0.80056131 |
| 81 | MP0003718_maternal_effect | 0.78021329 |
| 82 | MP0005387_immune_system_phenotype | 0.74571957 |
| 83 | MP0001790_abnormal_immune_system | 0.74571957 |
| 84 | MP0000490_abnormal_crypts_of | 0.74008593 |
| 85 | MP0000703_abnormal_thymus_morphology | 0.73343680 |
| 86 | MP0006138_congestive_heart_failure | 0.73159548 |
| 87 | MP0002735_abnormal_chemical_nociception | 0.72162646 |
| 88 | MP0005501_abnormal_skin_physiology | 0.70274835 |
| 89 | MP0005535_abnormal_body_temperature | 0.69192933 |
| 90 | MP0002998_abnormal_bone_remodeling | 0.68727832 |
| 91 | MP0001756_abnormal_urination | 0.67913147 |
| 92 | MP0006054_spinal_hemorrhage | 0.66633734 |
| 93 | MP0002118_abnormal_lipid_homeostasis | 0.66304590 |
| 94 | MP0003011_delayed_dark_adaptation | 0.66140769 |
| 95 | MP0005385_cardiovascular_system_phenoty | 0.65450928 |
| 96 | MP0001544_abnormal_cardiovascular_syste | 0.65450928 |
| 97 | MP0005023_abnormal_wound_healing | 0.63868200 |
| 98 | MP0005365_abnormal_bile_salt | 0.63862193 |
| 99 | MP0000358_abnormal_cell_content/ | 0.63637165 |
| 100 | MP0002653_abnormal_ependyma_morphology | 0.63573731 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal platelet volume (HP:0011876) | 9.77112285 |
| 2 | Petechiae (HP:0000967) | 9.61467316 |
| 3 | Purpura (HP:0000979) | 8.73828662 |
| 4 | Epistaxis (HP:0000421) | 7.87359009 |
| 5 | Gingival bleeding (HP:0000225) | 6.50347192 |
| 6 | Hyperlipoproteinemia (HP:0010980) | 6.19942958 |
| 7 | Impaired platelet aggregation (HP:0003540) | 5.64022730 |
| 8 | Abnormal platelet function (HP:0011869) | 5.64022730 |
| 9 | Dyschromatopsia (HP:0007641) | 4.57550244 |
| 10 | Spontaneous hematomas (HP:0007420) | 4.43708019 |
| 11 | Acanthocytosis (HP:0001927) | 4.14184927 |
| 12 | Poikilocytosis (HP:0004447) | 4.03920453 |
| 13 | Conjunctival telangiectasia (HP:0000524) | 3.83563842 |
| 14 | Bruising susceptibility (HP:0000978) | 3.41731672 |
| 15 | Paralysis (HP:0003470) | 3.36149806 |
| 16 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.35458041 |
| 17 | Abnormal pupillary function (HP:0007686) | 3.34991225 |
| 18 | Abnormality of the common coagulation pathway (HP:0010990) | 3.33386277 |
| 19 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.32772413 |
| 20 | Abnormality of lateral ventricle (HP:0030047) | 3.12056451 |
| 21 | Increased density of long bones (HP:0006392) | 2.94059527 |
| 22 | Decreased central vision (HP:0007663) | 2.89775264 |
| 23 | Hepatosplenomegaly (HP:0001433) | 2.71589732 |
| 24 | Increased IgM level (HP:0003496) | 2.64701725 |
| 25 | Stomatitis (HP:0010280) | 2.62334726 |
| 26 | Abnormal auditory evoked potentials (HP:0006958) | 2.57679831 |
| 27 | Joint hemorrhage (HP:0005261) | 2.55084356 |
| 28 | Joint swelling (HP:0001386) | 2.51550158 |
| 29 | Abnormality of macrophages (HP:0004311) | 2.48228747 |
| 30 | Xanthomatosis (HP:0000991) | 2.37522311 |
| 31 | Tinnitus (HP:0000360) | 2.31692430 |
| 32 | Spontaneous abortion (HP:0005268) | 2.30221761 |
| 33 | Upper limb muscle weakness (HP:0003484) | 2.27870016 |
| 34 | Male infertility (HP:0003251) | 2.27849042 |
| 35 | Abnormality of iron homeostasis (HP:0011031) | 2.25154696 |
| 36 | Generalized aminoaciduria (HP:0002909) | 2.23169196 |
| 37 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.16647855 |
| 38 | Papillary thyroid carcinoma (HP:0002895) | 2.16397776 |
| 39 | Encephalitis (HP:0002383) | 2.11880378 |
| 40 | Nausea (HP:0002018) | 2.08783219 |
| 41 | Thyroid-stimulating hormone excess (HP:0002925) | 2.05505566 |
| 42 | Hypophosphatemic rickets (HP:0004912) | 2.05382850 |
| 43 | Obstructive lung disease (HP:0006536) | 2.02310195 |
| 44 | Chronic obstructive pulmonary disease (HP:0006510) | 2.02310195 |
| 45 | Hyperthyroidism (HP:0000836) | 2.01753410 |
| 46 | Prolonged bleeding time (HP:0003010) | 11.7949193 |
| 47 | Menorrhagia (HP:0000132) | 10.4402718 |
| 48 | Increased mean platelet volume (HP:0011877) | 10.2964963 |
| 49 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.99701618 |
| 50 | 3-Methylglutaconic aciduria (HP:0003535) | 1.99630490 |
| 51 | Abnormal ciliary motility (HP:0012262) | 1.99200733 |
| 52 | Arterial thrombosis (HP:0004420) | 1.95037052 |
| 53 | Dysautonomia (HP:0002459) | 1.94012747 |
| 54 | Episodic fever (HP:0001954) | 1.93813034 |
| 55 | Ventricular fibrillation (HP:0001663) | 1.92171509 |
| 56 | Biliary tract neoplasm (HP:0100574) | 1.83533732 |
| 57 | Increased serum ferritin (HP:0003281) | 1.79753295 |
| 58 | Abnormality of the prostate (HP:0008775) | 1.75148735 |
| 59 | Polycythemia (HP:0001901) | 1.72071412 |
| 60 | Myocardial infarction (HP:0001658) | 1.67952281 |
| 61 | Autoimmune hemolytic anemia (HP:0001890) | 1.64339263 |
| 62 | Infertility (HP:0000789) | 1.63023563 |
| 63 | Vertigo (HP:0002321) | 1.62928644 |
| 64 | Absent/shortened dynein arms (HP:0200106) | 1.62921307 |
| 65 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.62921307 |
| 66 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.61128122 |
| 67 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.61128122 |
| 68 | Basal ganglia calcification (HP:0002135) | 1.60705145 |
| 69 | Thrombocytosis (HP:0001894) | 1.59034778 |
| 70 | Eczematoid dermatitis (HP:0000976) | 1.58450218 |
| 71 | Tongue fasciculations (HP:0001308) | 1.57278254 |
| 72 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.56991868 |
| 73 | Abnormality of alanine metabolism (HP:0010916) | 1.56028991 |
| 74 | Hyperalaninemia (HP:0003348) | 1.56028991 |
| 75 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.56028991 |
| 76 | Polyphagia (HP:0002591) | 1.55507253 |
| 77 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.54217452 |
| 78 | Chest pain (HP:0100749) | 1.52408262 |
| 79 | Central scotoma (HP:0000603) | 1.51539596 |
| 80 | Arthropathy (HP:0003040) | 1.51530424 |
| 81 | Muscle fibrillation (HP:0010546) | 1.49059487 |
| 82 | Renal Fanconi syndrome (HP:0001994) | 1.47338601 |
| 83 | Exertional dyspnea (HP:0002875) | 1.46035937 |
| 84 | Leiomyosarcoma (HP:0100243) | 1.45118992 |
| 85 | Uterine leiomyosarcoma (HP:0002891) | 1.45118992 |
| 86 | Distal lower limb amyotrophy (HP:0008944) | 1.44458496 |
| 87 | Thrombophlebitis (HP:0004418) | 1.43584718 |
| 88 | Testicular neoplasm (HP:0010788) | 1.41183624 |
| 89 | Thyroid carcinoma (HP:0002890) | 1.39686999 |
| 90 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.38819430 |
| 91 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.38210668 |
| 92 | Inflammation of the large intestine (HP:0002037) | 1.35379375 |
| 93 | Hypertriglyceridemia (HP:0002155) | 1.34388512 |
| 94 | Ileus (HP:0002595) | 1.33207726 |
| 95 | Mucosal telangiectasiae (HP:0100579) | 1.33064647 |
| 96 | Leukocytosis (HP:0001974) | 1.32315276 |
| 97 | Cerebral ischemia (HP:0002637) | 1.30724677 |
| 98 | Abnormal spermatogenesis (HP:0008669) | 1.30663356 |
| 99 | Abnormality of binocular vision (HP:0011514) | 1.30522269 |
| 100 | Diplopia (HP:0000651) | 1.30522269 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 5.03804603 |
| 2 | MST4 | 5.03248444 |
| 3 | BMX | 4.37206329 |
| 4 | MYLK | 3.52701288 |
| 5 | TEC | 3.35539781 |
| 6 | BTK | 3.19861981 |
| 7 | EIF2AK1 | 2.86283584 |
| 8 | TAOK3 | 2.76678190 |
| 9 | PTK2B | 2.72017375 |
| 10 | CSF1R | 2.36586952 |
| 11 | SYK | 2.23466750 |
| 12 | GRK5 | 2.21557034 |
| 13 | GRK6 | 2.18342333 |
| 14 | ZAP70 | 2.06367239 |
| 15 | ILK | 1.91213779 |
| 16 | PIK3CG | 1.89492598 |
| 17 | BMPR2 | 1.79349589 |
| 18 | FGR | 1.69626364 |
| 19 | TNK2 | 1.59292242 |
| 20 | MAPKAPK3 | 1.59012565 |
| 21 | ACVR1B | 1.55352354 |
| 22 | FES | 1.53445607 |
| 23 | HCK | 1.49754952 |
| 24 | MAP4K2 | 1.42578945 |
| 25 | STK3 | 1.40938135 |
| 26 | ADRBK2 | 1.40713162 |
| 27 | BLK | 1.38240881 |
| 28 | MAP2K3 | 1.31259889 |
| 29 | LYN | 1.22295042 |
| 30 | PAK1 | 1.20556693 |
| 31 | PLK2 | 1.20068100 |
| 32 | PIM2 | 1.17995668 |
| 33 | IKBKB | 1.17846607 |
| 34 | DAPK3 | 1.14327651 |
| 35 | LMTK2 | 1.11453284 |
| 36 | TLK1 | 1.07685171 |
| 37 | TXK | 1.04052937 |
| 38 | MATK | 1.03398399 |
| 39 | NUAK1 | 1.01594444 |
| 40 | ITK | 0.94819842 |
| 41 | ADRBK1 | 0.92466887 |
| 42 | TNIK | 0.89242577 |
| 43 | PNCK | 0.86061418 |
| 44 | ZAK | 0.84932807 |
| 45 | STK24 | 0.82770698 |
| 46 | MAP3K5 | 0.81229606 |
| 47 | RET | 0.80490841 |
| 48 | DAPK2 | 0.78461706 |
| 49 | MARK3 | 0.78305265 |
| 50 | CSK | 0.78082155 |
| 51 | IRAK1 | 0.78000568 |
| 52 | PRKD1 | 0.75074571 |
| 53 | BMPR1B | 0.74444250 |
| 54 | ARAF | 0.73583384 |
| 55 | PKN1 | 0.70218697 |
| 56 | MAP4K1 | 0.69244037 |
| 57 | TAOK2 | 0.63672008 |
| 58 | ERBB2 | 0.60923165 |
| 59 | EPHA3 | 0.59005499 |
| 60 | TESK2 | 0.58416563 |
| 61 | MAPK12 | 0.57478854 |
| 62 | LCK | 0.57181749 |
| 63 | FER | 0.56076451 |
| 64 | PDK1 | 0.54436429 |
| 65 | DAPK1 | 0.51739269 |
| 66 | TRIM28 | 0.48626596 |
| 67 | PRKACG | 0.48338684 |
| 68 | MAP3K11 | 0.48283636 |
| 69 | MAP3K3 | 0.47192531 |
| 70 | GRK1 | 0.45938019 |
| 71 | PRKCQ | 0.45339604 |
| 72 | SIK3 | 0.44805532 |
| 73 | PDPK1 | 0.44441908 |
| 74 | FYN | 0.44244373 |
| 75 | JAK3 | 0.41968364 |
| 76 | STK4 | 0.40218896 |
| 77 | MAP2K1 | 0.39897952 |
| 78 | MINK1 | 0.36408037 |
| 79 | JAK2 | 0.35778148 |
| 80 | PRKG1 | 0.35403015 |
| 81 | EPHB2 | 0.34919266 |
| 82 | PDGFRB | 0.33870376 |
| 83 | MAPK13 | 0.32585169 |
| 84 | PRKCD | 0.31282938 |
| 85 | DYRK1B | 0.30715052 |
| 86 | PIM1 | 0.30503248 |
| 87 | IRAK4 | 0.29900738 |
| 88 | TAOK1 | 0.29075199 |
| 89 | CAMKK2 | 0.29063110 |
| 90 | PRKCB | 0.27588180 |
| 91 | PAK3 | 0.27005696 |
| 92 | IRAK2 | 0.26877556 |
| 93 | PRKCA | 0.26765333 |
| 94 | IGF1R | 0.24295371 |
| 95 | SRC | 0.23651409 |
| 96 | FLT3 | 0.23346460 |
| 97 | DYRK1A | 0.21814260 |
| 98 | CDK14 | 0.21773870 |
| 99 | IRAK3 | 0.21553887 |
| 100 | EPHB1 | 0.20551310 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Platelet activation_Homo sapiens_hsa04611 | 5.65203991 |
| 2 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 3.50043960 |
| 3 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 3.20409971 |
| 4 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.75260460 |
| 5 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.45001226 |
| 6 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.38501640 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.08043963 |
| 8 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.06328840 |
| 9 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.90580441 |
| 10 | Gap junction_Homo sapiens_hsa04540 | 1.90145091 |
| 11 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.77964047 |
| 12 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.70365149 |
| 13 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.61211614 |
| 14 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.54370828 |
| 15 | Alcoholism_Homo sapiens_hsa05034 | 1.54211278 |
| 16 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.53574597 |
| 17 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.41811115 |
| 18 | Endocytosis_Homo sapiens_hsa04144 | 1.30566925 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.27460087 |
| 20 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.26576831 |
| 21 | Shigellosis_Homo sapiens_hsa05131 | 1.25579531 |
| 22 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.15257517 |
| 23 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.14944539 |
| 24 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.14850907 |
| 25 | Olfactory transduction_Homo sapiens_hsa04740 | 1.14343308 |
| 26 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.06516414 |
| 27 | Long-term depression_Homo sapiens_hsa04730 | 1.04341030 |
| 28 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.02628403 |
| 29 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.01355087 |
| 30 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.00438325 |
| 31 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.00369756 |
| 32 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.99919456 |
| 33 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.98545067 |
| 34 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.97614280 |
| 35 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.96901258 |
| 36 | Mismatch repair_Homo sapiens_hsa03430 | 0.95705754 |
| 37 | Circadian entrainment_Homo sapiens_hsa04713 | 0.94275733 |
| 38 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.91836397 |
| 39 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.90203389 |
| 40 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.90044527 |
| 41 | Morphine addiction_Homo sapiens_hsa05032 | 0.88901289 |
| 42 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.88503325 |
| 43 | Malaria_Homo sapiens_hsa05144 | 0.84914366 |
| 44 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.82759954 |
| 45 | Phagosome_Homo sapiens_hsa04145 | 0.82716429 |
| 46 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.82025807 |
| 47 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.81034491 |
| 48 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.76442655 |
| 49 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.76437413 |
| 50 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.75258612 |
| 51 | Asthma_Homo sapiens_hsa05310 | 0.73707412 |
| 52 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.73444439 |
| 53 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.71075591 |
| 54 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.69746868 |
| 55 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.69539257 |
| 56 | Phototransduction_Homo sapiens_hsa04744 | 0.69293176 |
| 57 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66438959 |
| 58 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.65736830 |
| 59 | Focal adhesion_Homo sapiens_hsa04510 | 0.64905404 |
| 60 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.64727412 |
| 61 | Allograft rejection_Homo sapiens_hsa05330 | 0.64292714 |
| 62 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.63107270 |
| 63 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.63082359 |
| 64 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.62817571 |
| 65 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.61079182 |
| 66 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.60412789 |
| 67 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.60356421 |
| 68 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.59327232 |
| 69 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.58979377 |
| 70 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.57878821 |
| 71 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.57398366 |
| 72 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.54844396 |
| 73 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.54387340 |
| 74 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.52947902 |
| 75 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.50702638 |
| 76 | GABAergic synapse_Homo sapiens_hsa04727 | 0.50138675 |
| 77 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.49949282 |
| 78 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.49606049 |
| 79 | Renin secretion_Homo sapiens_hsa04924 | 0.48179244 |
| 80 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.47872941 |
| 81 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.47529116 |
| 82 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.46998325 |
| 83 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.46910719 |
| 84 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.46178731 |
| 85 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.44616519 |
| 86 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.43457931 |
| 87 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.42432897 |
| 88 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.42298348 |
| 89 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.41863755 |
| 90 | Melanoma_Homo sapiens_hsa05218 | 0.41376816 |
| 91 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.41298869 |
| 92 | Endometrial cancer_Homo sapiens_hsa05213 | 0.41041467 |
| 93 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.40622790 |
| 94 | Apoptosis_Homo sapiens_hsa04210 | 0.40094963 |
| 95 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.39873756 |
| 96 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.37218910 |
| 97 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.36252360 |
| 98 | Salmonella infection_Homo sapiens_hsa05132 | 0.34877437 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.34435895 |
| 100 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.34134715 |

